KSQ Therapeutics
Thomas Leitch, Chief Technology Officer Tom brings more than 20 years of leadership experience in cell and gene therapy, biologics, and vaccines. His experience spans Manufacturing Sciences, CMC Strategy Development, Internal and External Manufacturing Operations, Quality, Engineering, Tech Transfer, and Supply Chain across a broad range of leading biopharmaceutical companies
Leitch came to KSQ from bluebird bio, where, as head of Manufacturing, he led the development and execution of the company's manufacturing strategy during a period of rapid growth that expanded the network to include more than ten internal and external manufacturing sites around the world. Before bluebird, Tom held roles at Alexion and Merck. He holds M.S. and B.S. degrees in engineering from Virginia Tech.
This person is not in any teams
This person is not in any offices
KSQ Therapeutics
KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed.